Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-26 @ 11:11 AM
NCT ID:
NCT06641128
Eligibility Criteria:
Inclusion Criteria:
* Patients with active rheumatoid arthritis (not in remission) according to 28 joints disease activity score (DAS-28)
* Age range between 18 and 60 years old.
* Both sexes.
* Body mass index (BMI), age, disease activity, and disease duration matched patients.
Exclusion Criteria:
* Patients with renal or hepatic diseases (chronic liver disease, liver cirrhosis, alcoholic hepatitis, or chronic alcoholism).
* Patients receiving biological DMARDs during 4 weeks before the first dose of Empa.
* Patients with hypersensitivity to study medications.
* Patients using antioxidants except Empa.
* Pregnant and lactating females.
* Pre-existing blood disorders, such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or significant anemia.
* Patient with HIV/AIDS, blood dyscrasias, or radiotherapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT06641128
Study Brief:
Protocol Section:
NCT06641128